{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19116", "batch_size": 200, "batch_pos": 155, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb or potent metaphor.", "method": "llm_batch", "batch_id": "batch_2_15160", "batch_size": 200, "batch_pos": 148, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The statement describes a future plan, not realised impact.", "method": "llm_batch", "batch_id": "batch_3_3996", "batch_size": 200, "batch_pos": 124, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_19364", "batch_size": 200, "batch_pos": 122, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment discusses timing of testing, which is not a calming cue.", "method": "llm_batch", "batch_id": "batch_5_6456", "batch_size": 200, "batch_pos": 120, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_5764", "batch_size": 200, "batch_pos": 111, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_16996", "batch_size": 200, "batch_pos": 106, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "uncertain", "rationale": "LLM call failed.", "method": "llm_batch", "batch_id": "batch_8_6524", "batch_size": 200, "batch_pos": 64, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment reports testing plans and timing, not prices or economic metrics.", "method": "llm_batch", "batch_id": "batch_9_20260", "batch_size": 200, "batch_pos": 134, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states future plans/expectations, not speculation about relief from the threat.", "method": "llm_batch", "batch_id": "batch_10_19676", "batch_size": 200, "batch_pos": 87, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Attribution 'said' but no direct quote text.", "method": "llm_batch", "batch_id": "batch_11_16436", "batch_size": 200, "batch_pos": 81, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Q12 reached. No explicit framing cues found. Facts presented factually.", "method": "llm_batch", "batch_id": "batch_12_19472", "batch_size": 200, "batch_pos": 81, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
